Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences

from Few & Far Between: How Biotech Gets Built · host Chris O'Brien

What if the future of biotech is actually late-stage execution? Welcome to our first video episode of the Biorasi Few & Far Between podcast with your host, Chris O’Brien. Today, we welcome guest Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences. We’ll be covering a myriad of biotech topics, from “business athletes” to the role of the operating company in the drug development industry. We’ll also be premiering our lightning round - quick questions and inspired answers from our podcast guests. Okay, let’s start the podcast!

Episode metadata supplied by the publisher feed · Published Oct 28, 2025

Embed this episode

Attribution link and audio player

Ready to play

Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences

0:00 1:01:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Few & Far Between: How Biotech Gets Built?

This episode is 1 hour and 1 minute long.

When was this Few & Far Between: How Biotech Gets Built episode published?

This episode was published on October 28, 2025.

Can I download this Few & Far Between: How Biotech Gets Built episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!